How do you approach the treatment of de novo, brain only metastatic HER2 positive breast cancer?
Answer from: Medical Oncologist at Academic Institution
Patients who present with de novo, brain-only metastases of HER2+ breast cancer are rare, and hence, there is no good clinical experience or clinical trial basis upon which to base clinical practice recommendations. The current ASCO guidelines for the management of HER2+ brain metastases call for ap...
Comments
Medical Oncologist at Hoag Health System Would anyone use tucatinib+tras+/-xeloda based on ...
Medical Oncologist at University of Texas MD Anderson Cancer Center It is appealing to add cytotoxic therapy in a situ...
Medical Oncologist at Baylor-Charles A Sammons Cancer Center Would this maintenance period of HP be long term v...
Medical Oncologist at University of Texas MD Anderson Cancer Center For patients with metastatic disease, the conventi...
Would anyone use tucatinib+tras+/-xeloda based on ...
It is appealing to add cytotoxic therapy in a situ...
Would this maintenance period of HP be long term v...
For patients with metastatic disease, the conventi...